Literature DB >> 28590207

An Integrative Approach to Treatment-Resistant Obsessive-Compulsive Disorder.

Luke Sy-Cherng Woon1, Anita Kanapathy1, Hazli Zakaria1, César A Alfonso1,2.   

Abstract

Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder that often runs a chronic unremitting course. Treatment outcomes can be unsatisfactory despite the availability of various somatic and psychological therapies. Psychodynamic psychotherapy in combination with cognitive behavioral therapy (CBT) with exposure and response prevention (ERP) could help patients with treatment-resistant OCD achieve better outcomes. An integrative approach can help patients gain insight, strengthen the therapeutic alliance, improve treatment adherence, and provide symptomatic relief when other treatments seem insufficient or have failed. We describe the treatment process of a person with treatment-resistant OCD who received pharmacotherapy, concurrent CBT/ERP, and a brief course of psychodynamic psychotherapy. Case formulations from cognitive behavioral and psychodynamic perspectives are presented. The authors discuss the advantages of doing a psychodynamic assessment and formulation in treatment refractory cases and the wisdom of integrating psychotherapy interventions for OCD, as well as the unique clinical features of cases that warrant a multimodal treatment approach.

Entities:  

Keywords:  cognitive behavioral therapy; combination of psychotherapies; exposure and response prevention; obsessive-compulsive disorder; psychodynamic psychotherapy; treatment resistance

Mesh:

Year:  2017        PMID: 28590207     DOI: 10.1521/pdps.2017.45.2.237

Source DB:  PubMed          Journal:  Psychodyn Psychiatry        ISSN: 2162-2590


  1 in total

1.  Psychodynamic psychotherapy training in South East Asia: a distance learning pilot program.

Authors:  César A Alfonso; Limas Sutanto; Hazli Zakaria; Rasmon Kalayasiri; Petrin Redayani Lukman; Sylvia Detri Elvira; Aida Syarinaz Ahmad Adlan
Journal:  BJPsych Int       Date:  2018-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.